INC Research (INCR) Trading Down 5.7%
INC Research Holdings Inc (NASDAQ:INCR) fell 5.7% on Thursday . The company traded as low as $40.50 and last traded at $41.30. 1,958,274 shares were traded during mid-day trading, an increase of 61% from the average session volume of 1,219,125 shares. The stock had previously closed at $43.80.
A number of brokerages have recently weighed in on INCR. TheStreet upgraded shares of INC Research from a “c” rating to a “b-” rating in a report on Monday, November 6th. Credit Suisse Group began coverage on shares of INC Research in a report on Wednesday, October 11th. They issued an “outperform” rating and a $68.00 price objective for the company. Jefferies Group upgraded shares of INC Research from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $62.50 to $69.00 in a report on Monday, October 9th. Robert W. Baird reaffirmed a “buy” rating and issued a $67.00 target price on shares of INC Research in a research note on Monday, October 9th. Finally, Zacks Investment Research downgraded shares of INC Research from a “buy” rating to a “hold” rating in a research note on Wednesday, October 4th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and seven have assigned a buy rating to the company’s stock. INC Research currently has a consensus rating of “Buy” and an average price target of $50.78.
The company has a debt-to-equity ratio of 0.99, a current ratio of 1.27 and a quick ratio of 1.27. The company has a market cap of $4,309.45, a P/E ratio of 18.94, a P/E/G ratio of 1.27 and a beta of 1.09.
INC Research (NASDAQ:INCR) last issued its earnings results on Thursday, November 9th. The company reported $0.54 EPS for the quarter, missing the consensus estimate of $0.63 by ($0.09). INC Research had a positive return on equity of 14.42% and a negative net margin of 4.29%. The firm had revenue of $592.21 million during the quarter, compared to analysts’ expectations of $604.95 million. During the same period in the previous year, the firm earned $0.64 earnings per share. The firm’s quarterly revenue was up 128.2% compared to the same quarter last year. equities research analysts expect that INC Research Holdings Inc will post 2.15 EPS for the current fiscal year.
A number of institutional investors have recently modified their holdings of INCR. Lee Thomas H Partners LP purchased a new position in INC Research during the 3rd quarter valued at $1,316,644,000. BlackRock Inc. increased its position in INC Research by 82.3% during the 2nd quarter. BlackRock Inc. now owns 6,461,899 shares of the company’s stock valued at $378,020,000 after purchasing an additional 2,917,605 shares during the period. Janus Henderson Group PLC purchased a new position in INC Research during the 2nd quarter valued at $99,424,000. State Street Corp increased its position in INC Research by 112.8% during the 2nd quarter. State Street Corp now owns 1,769,353 shares of the company’s stock valued at $103,508,000 after purchasing an additional 937,864 shares during the period. Finally, Point72 Asset Management L.P. increased its position in INC Research by 1,337.6% during the 3rd quarter. Point72 Asset Management L.P. now owns 598,039 shares of the company’s stock valued at $31,277,000 after purchasing an additional 556,439 shares during the period. 99.50% of the stock is currently owned by institutional investors and hedge funds.
About INC Research
INC Research Holdings, Inc is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services.
Receive News & Ratings for INC Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INC Research and related companies with Analyst Ratings Network's FREE daily email newsletter.